Search Results 561-570 of 14789 for anti-TNF drugs

1. Beta-Adrenergic Blocker (Ophthalmic Route) Before Using - Mayo Clinic

   Ophthalmic beta-adrenergic blocking agents may be absorbed into the body. These medicines have not been studied in pregnant women. Studies in animals have not ...

2. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Prior treatment with anti-CD38 therapy including daratumumab (Cohorts D1, D2, E, F). Participating Mayo Clinic locations. Study statuses change often. Please ...

3. CAR-T Cell Therapy Program

   Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...

4. Clotrimazole (Topical Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Clotrim Antifungal; Cruex Prescription Strength; Lotrimin ...

5. Antithyroid Agent (Oral Route, Rectal Route) Description and Brand Names - Mayo Clinic

   These medicines work by making it harder for the body to use iodine to make thyroid hormone. They do not block the effects of thyroid hormone that was made ...

6. Methotrexate (Injection Route, Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Flurbiprofen (Oral Route) Precautions - Mayo Clinic

   Although this is rare, it may occur often in patients who are allergic to aspirin or other nonsteroidal anti-inflammatory drugs. Anaphylaxis requires ...

8. Tapering off opioids: When and how - Mayo Clinic

   Most people using opioid medicines need to stop as soon as possible to prevent serious health risks. Learn how to slowly lower and safely stop opioid use.

9. A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) - Mayo Clinic

   A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin ...

10. Some pain medicines may increase heart attack risk after surgery - Mayo Clinic News Network

    In a McGill University study published recently in the British Medical Journal, researchers found that post-surgery use of nonsteroidal anti-inflammatory drugs ...